" class="no-js "lang="en-US"> Martin Blüggel - Medtech Alert
Monday, August 18, 2025
Martin Blüggel

Martin Blüggel

About Martin Blüggel

CEO and co-founder of Protagen Protein Services (PPS). Passionate entrepreneur with a demonstrated history of market experience and GMP-compliance expertise. Skilled in management and dedicated to the journey of leadership. Working with a team of devoted and highly-skilled experts in the field of analytical services for biotherapeutics.
Originally founded as a protein analysis services company, PPS today is a world leading CRO and – as a recognized expert in mass spectrometry methods for analytical services in protein science and gene therapy – offers a comprehensive spectrum of state-of-the-art analytical methods. A broad range of validated analytical methods ensures the highest quality for our customers in the pharmaceutical, biotech and life science industry. All-in-one-hand service including full analytical support, complete documentation and outstanding project management.

Related Story

Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms

July 2 2021

Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio […]